Report Detail

Request for Sample of this report

Other Global Non-Oncology Precision Medicine Key Trends and Opportunities to 2027

  • RnM4265468
    • |
  • 15 March, 2021
    • |
  • Global
    • |
  • 181 Pages
    • |
  • QYResearch
    • |
  • Other

Non-Oncology Precision Medicine market is segmented by companies, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non-Oncology Precision Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on market size and forecast for the period 2016-2027.
Segment by Type, the Non-Oncology Precision Medicine market is segmented into Applied Sciences, Precision Diagnostics, Digital Health and Information Technology, Precision Therapeutics, etc.
Segment by Application, the Non-Oncology Precision Medicine market is segmented into Infectious Diseases, Neurology, Cardiovascular, Lifestyle and Endocrinology, Gastroenterology, Others, etc.

Regional and Country-level Analysis
The report offers exhaustive assessment of different region-wise and country-wise Non-Oncology Precision Medicine markets such as the U.S., Canada, Germany, France, the U.K., Italy, Russia, China, Japan, South Korea, Taiwan, India, Australia, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Argentina, Saudi Arabia, UAE, Turkey, etc.
The report includes country-wise and region-wise market size for the period 2016-2027, by countries (regions), by Type, and by Application, as well as by players for North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Competitive Landscape and Non-Oncology Precision Medicine Market Share Analysis
Non-Oncology Precision Medicine market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2016-2021. Details included are company description, major business, company total revenue and revenue generated in Non-Oncology Precision Medicine business, the date to enter into the Non-Oncology Precision Medicine market, Non-Oncology Precision Medicine product introduction, recent developments, etc.
The major vendors include Abbott Laboratories, Agilent Technologies, Inc., Asuragen, Inc., Almac Group, AstraZeneca PLC, Bristol Myers Squibb, bioMérieux SA., BGI, Danaher Corp., Illumina, Inc., Invitae Corporation, Opko Health, Inc., Teva Pharmaceutical Industries Ltd., etc.


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Non-Oncology Precision Medicine Market Size by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Applied Sciences
    • 1.2.3 Precision Diagnostics
    • 1.2.4 Digital Health and Information Technology
    • 1.2.5 Precision Therapeutics
  • 1.3 Market by Application
    • 1.3.1 Global Non-Oncology Precision Medicine Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Infectious Diseases
    • 1.3.3 Neurology
    • 1.3.4 Cardiovascular
    • 1.3.5 Lifestyle and Endocrinology
    • 1.3.6 Gastroenterology
    • 1.3.7 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trend

  • 2.1 Global Non-Oncology Precision Medicine Market Perspective (2016-2027)
  • 2.2 Global Non-Oncology Precision Medicine Growth Trends by Regions
    • 2.2.1 Non-Oncology Precision Medicine Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Non-Oncology Precision Medicine Historic Market Size by Regions (2016-2021)
    • 2.2.3 Non-Oncology Precision Medicine Forecasted Market Size by Regions (2022-2027)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Non-Oncology Precision Medicine Industry Trends
    • 2.3.2 Non-Oncology Precision Medicine Market Drivers
    • 2.3.3 Non-Oncology Precision Medicine Market Challenges
    • 2.3.4 Non-Oncology Precision Medicine Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Non-Oncology Precision Medicine Players by Market Size
    • 3.1.1 Players Covered: Ranking by Non-Oncology Precision Medicine Revenue
    • 3.1.2 Global Top Non-Oncology Precision Medicine Players by Revenue (2016-2021)
    • 3.1.3 Global Non-Oncology Precision Medicine Revenue Market Share by Players (2016-2021)
    • 3.1.4 Global Non-Oncology Precision Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Non-Oncology Precision Medicine Market Concentration Ratio
    • 3.2.1 Global Non-Oncology Precision Medicine Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 5 and Top 10 Players by Non-Oncology Precision Medicine Revenue in 2020
  • 3.3 Non-Oncology Precision Medicine Key Players Head office and Area Served
  • 3.4 Key Players Non-Oncology Precision Medicine Product Solution and Service
  • 3.5 Date of Enter into Non-Oncology Precision Medicine Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Global Non-Oncology Precision Medicine Breakdown Data by Type (2016-2027)

  • 4.1 Global Non-Oncology Precision Medicine Historic Market Size by Type (2016-2021)
  • 4.2 Global Non-Oncology Precision Medicine Forecasted Market Size by Type (2022-2027)

5 Global Non-Oncology Precision Medicine Breakdown Data by Application (2016-2027)

  • 5.1 Global Non-Oncology Precision Medicine Historic Market Size by Application (2016-2021)
  • 5.2 Non-Oncology Precision Medicine Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Non-Oncology Precision Medicine Market Size (2016-2027)
  • 6.2 Key Non-Oncology Precision Medicine Players Market Share in North America (2020-2021)
  • 6.3 North America Non-Oncology Precision Medicine Market Size by Country
    • 6.3.1 North America Non-Oncology Precision Medicine Sales by Country (2016-2021)
    • 6.3.2 North America Non-Oncology Precision Medicine Market Size Forecast by Country (2022-2027)
  • 6.4 U.S. Market Size Analysis
    • 6.4.1 U.S. Non-Oncology Precision Medicine Market Size (2016-2027)
    • 6.4.2 U.S. Non-Oncology Precision Medicine Market Size by Type (2016-2027)
    • 6.4.3 U.S. Non-Oncology Precision Medicine Market Size by Application (2016-2027)
  • 6.5 Canada Market Size Analysis
    • 6.5.1 Canada Non-Oncology Precision Medicine Market Size (2016-2027)
    • 6.5.2 Canada Non-Oncology Precision Medicine Market Size by Type (2016-2027)
    • 6.5.3 Canada Non-Oncology Precision Medicine Market Size by Application (2016-2027)

7 Europe

  • 7.1 Europe Non-Oncology Precision Medicine Market Size (2016-2027)
  • 7.2 Key Non-Oncology Precision Medicine Players Market Share in Europe (2020-2021)
  • 7.3 Europe Non-Oncology Precision Medicine Market Size by Country
    • 7.3.1 Europe Non-Oncology Precision Medicine Sales by Country (2016-2021)
    • 7.3.2 Europe Non-Oncology Precision Medicine Market Size Forecast by Country (2022-2027)
  • 7.4 Germany Market Size Analysis
    • 7.4.1 Germany Non-Oncology Precision Medicine Market Size (2016-2027)
    • 7.4.2 Germany Non-Oncology Precision Medicine Market Size by Type (2016-2027)
    • 7.4.3 Germany Non-Oncology Precision Medicine Market Size by Application (2016-2027)
  • 7.5 France Market Size Analysis
    • 7.5.1 France Non-Oncology Precision Medicine Market Size (2016-2027)
    • 7.5.2 France Non-Oncology Precision Medicine Market Size by Type (2016-2027)
    • 7.5.3 France Non-Oncology Precision Medicine Market Size by Application (2016-2027)
  • 7.6 U.K. Market Size Analysis
    • 7.6.1 U.K. Non-Oncology Precision Medicine Market Size (2016-2027)
    • 7.6.2 U.K. Non-Oncology Precision Medicine Market Size by Type (2016-2027)
    • 7.6.3 U.K. Non-Oncology Precision Medicine Market Size by Application (2016-2027)
  • 7.7 Italy Market Size Analysis
    • 7.7.1 Italy Non-Oncology Precision Medicine Market Size (2016-2027)
    • 7.7.2 Italy Non-Oncology Precision Medicine Market Size by Type (2016-2027)
    • 7.7.3 Italy Non-Oncology Precision Medicine Market Size by Application (2016-2027)
  • 7.8 Russia Market Size Analysis
    • 7.8.1 Russia Non-Oncology Precision Medicine Market Size (2016-2027)
    • 7.8.2 Russia Non-Oncology Precision Medicine Market Size by Type (2016-2027)
    • 7.8.3 Russia Non-Oncology Precision Medicine Market Size by Application (2016-2027)

8 Asia-Pacific

  • 8.1 Asia-Pacific Non-Oncology Precision Medicine Market Size (2016-2027)
  • 8.2 Key Non-Oncology Precision Medicine Players Market Share in Asia-Pacific (2020-2021)
  • 8.3 Asia-Pacific Non-Oncology Precision Medicine Market Size by Region
    • 8.3.1 Asia-Pacific Non-Oncology Precision Medicine Sales by Region (2016-2021)
    • 8.3.2 Asia-Pacific Non-Oncology Precision Medicine Market Size Forecast by Region (2022-2027)
  • 8.4 China Market Size Analysis
    • 8.4.1 China Non-Oncology Precision Medicine Market Size (2016-2027)
    • 8.4.2 China Non-Oncology Precision Medicine Market Size by Type (2016-2027)
    • 8.4.3 China Non-Oncology Precision Medicine Market Size by Application (2016-2027)
  • 8.5 Japan Market Size Analysis
    • 8.5.1 Japan Non-Oncology Precision Medicine Market Size (2016-2027)
    • 8.5.2 Japan Non-Oncology Precision Medicine Market Size by Type (2016-2027)
    • 8.5.3 Japan Non-Oncology Precision Medicine Market Size by Application (2016-2027)
  • 8.6 South Korea Market Size Analysis
    • 8.6.1 South Korea Non-Oncology Precision Medicine Market Size (2016-2027)
    • 8.6.2 South Korea Non-Oncology Precision Medicine Market Size by Type (2016-2027)
    • 8.6.3 South Korea Non-Oncology Precision Medicine Market Size by Application (2016-2027)
  • 8.7 India Market Size Analysis
    • 8.7.1 India Non-Oncology Precision Medicine Market Size (2016-2027)
    • 8.7.2 India Non-Oncology Precision Medicine Market Size by Type (2016-2027)
    • 8.7.3 India Non-Oncology Precision Medicine Market Size by Application (2016-2027)
  • 8.8 Australia Market Size Analysis
    • 8.8.1 Australia Non-Oncology Precision Medicine Market Size (2016-2027)
    • 8.8.2 Australia Non-Oncology Precision Medicine Market Size by Type (2016-2027)
    • 8.8.3 Australia Non-Oncology Precision Medicine Market Size by Application (2016-2027)
  • 8.9 Taiwan Market Size Analysis
    • 8.9.1 Taiwan Non-Oncology Precision Medicine Market Size (2016-2027)
    • 8.9.2 Taiwan Non-Oncology Precision Medicine Market Size by Type (2016-2027)
    • 8.9.3 Taiwan Non-Oncology Precision Medicine Market Size by Application (2016-2027)
  • 8.10 Indonesia Market Size Analysis
    • 8.10.1 Indonesia Non-Oncology Precision Medicine Market Size (2016-2027)
    • 8.10.2 Indonesia Non-Oncology Precision Medicine Market Size by Type (2016-2027)
    • 8.10.3 Indonesia Non-Oncology Precision Medicine Market Size by Application (2016-2027)
  • 8.11 Thailand Market Size Analysis
    • 8.11.1 Thailand Non-Oncology Precision Medicine Market Size (2016-2027)
    • 8.11.2 Thailand Non-Oncology Precision Medicine Market Size by Type (2016-2027)
    • 8.11.3 Thailand Non-Oncology Precision Medicine Market Size by Application (2016-2027)
  • 8.12 Malaysia Market Size Analysis
    • 8.12.1 Malaysia Non-Oncology Precision Medicine Market Size (2016-2027)
    • 8.12.2 Malaysia Non-Oncology Precision Medicine Market Size by Type (2016-2027)
    • 8.12.3 Malaysia Non-Oncology Precision Medicine Market Size by Application (2016-2027)
  • 8.13 Philippines Market Size Analysis
    • 8.13.1 Philippines Non-Oncology Precision Medicine Market Size (2016-2027)
    • 8.13.2 Philippines Non-Oncology Precision Medicine Market Size by Type (2016-2027)
    • 8.13.3 Philippines Non-Oncology Precision Medicine Market Size by Application (2016-2027)
  • 8.14 Vietnam Market Size Analysis
    • 8.14.1 Vietnam Non-Oncology Precision Medicine Market Size (2016-2027)
    • 8.14.2 Vietnam Non-Oncology Precision Medicine Market Size by Type (2016-2027)
    • 8.14.3 Vietnam Non-Oncology Precision Medicine Market Size by Application (2016-2027)

9 Latin America

  • 9.1 Latin America Non-Oncology Precision Medicine Market Size (2016-2027)
  • 9.2 Key Non-Oncology Precision Medicine Players Market Share in Latin America (2020-2021)
  • 9.3 Latin America Non-Oncology Precision Medicine Market Size by Country
    • 9.3.1 Latin America Non-Oncology Precision Medicine Sales by Country (2016-2021)
    • 9.3.2 Latin America Non-Oncology Precision Medicine Market Size Forecast by Country (2022-2027)
  • 9.4 Mexico Market Size Analysis
    • 9.4.1 Mexico Non-Oncology Precision Medicine Market Size (2016-2027)
    • 9.4.2 Mexico Non-Oncology Precision Medicine Market Size by Type (2016-2027)
    • 9.4.3 Mexico Non-Oncology Precision Medicine Market Size by Application (2016-2027)
  • 9.5 Brazil Market Size Analysis
    • 9.5.1 Brazil Non-Oncology Precision Medicine Market Size (2016-2027)
    • 9.5.2 Brazil Non-Oncology Precision Medicine Market Size by Type (2016-2027)
    • 9.5.3 Brazil Non-Oncology Precision Medicine Market Size by Application (2016-2027)
  • 9.6 Argentina Market Size Analysis
    • 9.6.1 Argentina Non-Oncology Precision Medicine Market Size (2016-2027)
    • 9.6.2 Argentina Non-Oncology Precision Medicine Market Size by Type (2016-2027)
    • 9.6.3 Argentina Non-Oncology Precision Medicine Market Size by Application (2016-2027)

10 Middle East & Africa

  • 10.1 Middle East & Africa Non-Oncology Precision Medicine Market Size (2016-2027)
  • 10.2 Key Non-Oncology Precision Medicine Players Market Share in Middle East & Africa (2020-2021)
  • 10.3 Middle East & Africa Non-Oncology Precision Medicine Market Size by Country
    • 10.3.1 Middle East & Africa Non-Oncology Precision Medicine Sales by Country (2016-2021)
    • 10.3.2 Middle East & Africa Non-Oncology Precision Medicine Market Size Forecast by Country (2022-2027)
  • 10.4 Turkey Market Size Analysis
    • 10.4.1 Turkey Non-Oncology Precision Medicine Market Size (2016-2027)
    • 10.4.2 Turkey Non-Oncology Precision Medicine Market Size by Type (2016-2027)
    • 10.4.3 Turkey Non-Oncology Precision Medicine Market Size by Application (2016-2027)
  • 10.5 Saudi Arabia Market Size Analysis
    • 10.5.1 Saudi Arabia Non-Oncology Precision Medicine Market Size (2016-2027)
    • 10.5.2 Saudi Arabia Non-Oncology Precision Medicine Market Size by Type (2016-2027)
    • 10.5.3 Saudi Arabia Non-Oncology Precision Medicine Market Size by Application (2016-2027)
  • 10.6 UAE Market Size Analysis
    • 10.6.1 UAE Non-Oncology Precision Medicine Market Size (2016-2027)
    • 10.6.2 UAE Non-Oncology Precision Medicine Market Size by Type (2016-2027)
    • 10.6.3 UAE Non-Oncology Precision Medicine Market Size by Application (2016-2027)

11 Key Players Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Company Details
    • 11.1.2 Abbott Laboratories Business Overview and Its Total Revenue
    • 11.1.3 Abbott Laboratories Non-Oncology Precision Medicine Introduction
    • 11.1.4 Abbott Laboratories Revenue in Non-Oncology Precision Medicine Business (2016-2021)
    • 11.1.5 Abbott Laboratories Recent Development
  • 11.2 Agilent Technologies, Inc.
    • 11.2.1 Agilent Technologies, Inc. Company Details
    • 11.2.2 Agilent Technologies, Inc. Business Overview and Its Total Revenue
    • 11.2.3 Agilent Technologies, Inc. Non-Oncology Precision Medicine Introduction
    • 11.2.4 Agilent Technologies, Inc. Revenue in Non-Oncology Precision Medicine Business (2016-2021)
    • 11.2.5 Agilent Technologies, Inc. Recent Development
  • 11.3 Asuragen, Inc.
    • 11.3.1 Asuragen, Inc. Company Details
    • 11.3.2 Asuragen, Inc. Business Overview and Its Total Revenue
    • 11.3.3 Asuragen, Inc. Non-Oncology Precision Medicine Introduction
    • 11.3.4 Asuragen, Inc. Revenue in Non-Oncology Precision Medicine Business (2016-2021)
    • 11.3.5 Asuragen, Inc. Recent Development
  • 11.4 Almac Group
    • 11.4.1 Almac Group Company Details
    • 11.4.2 Almac Group Business Overview and Its Total Revenue
    • 11.4.3 Almac Group Non-Oncology Precision Medicine Introduction
    • 11.4.4 Almac Group Revenue in Non-Oncology Precision Medicine Business (2016-2021)
    • 11.4.5 Almac Group Recent Development
  • 11.5 AstraZeneca PLC
    • 11.5.1 AstraZeneca PLC Company Details
    • 11.5.2 AstraZeneca PLC Business Overview and Its Total Revenue
    • 11.5.3 AstraZeneca PLC Non-Oncology Precision Medicine Introduction
    • 11.5.4 AstraZeneca PLC Revenue in Non-Oncology Precision Medicine Business (2016-2021)
    • 11.5.5 AstraZeneca PLC Recent Development
  • 11.6 Bristol Myers Squibb
    • 11.6.1 Bristol Myers Squibb Company Details
    • 11.6.2 Bristol Myers Squibb Business Overview and Its Total Revenue
    • 11.6.3 Bristol Myers Squibb Non-Oncology Precision Medicine Introduction
    • 11.6.4 Bristol Myers Squibb Revenue in Non-Oncology Precision Medicine Business (2016-2021)
    • 11.6.5 Bristol Myers Squibb Recent Development
  • 11.7 bioMérieux SA.
    • 11.7.1 bioMérieux SA. Company Details
    • 11.7.2 bioMérieux SA. Business Overview and Its Total Revenue
    • 11.7.3 bioMérieux SA. Non-Oncology Precision Medicine Introduction
    • 11.7.4 bioMérieux SA. Revenue in Non-Oncology Precision Medicine Business (2016-2021)
    • 11.7.5 bioMérieux SA. Recent Development
  • 11.8 BGI
    • 11.8.1 BGI Company Details
    • 11.8.2 BGI Business Overview and Its Total Revenue
    • 11.8.3 BGI Non-Oncology Precision Medicine Introduction
    • 11.8.4 BGI Revenue in Non-Oncology Precision Medicine Business (2016-2021)
    • 11.8.5 BGI Recent Development
  • 11.9 Danaher Corp.
    • 11.9.1 Danaher Corp. Company Details
    • 11.9.2 Danaher Corp. Business Overview and Its Total Revenue
    • 11.9.3 Danaher Corp. Non-Oncology Precision Medicine Introduction
    • 11.9.4 Danaher Corp. Revenue in Non-Oncology Precision Medicine Business (2016-2021)
    • 11.9.5 Danaher Corp. Recent Development
  • 11.10 Illumina, Inc.
    • 11.10.1 Illumina, Inc. Company Details
    • 11.10.2 Illumina, Inc. Business Overview and Its Total Revenue
    • 11.10.3 Illumina, Inc. Non-Oncology Precision Medicine Introduction
    • 11.10.4 Illumina, Inc. Revenue in Non-Oncology Precision Medicine Business (2016-2021)
    • 11.10.5 Illumina, Inc. Recent Development
  • 11.11 Invitae Corporation
    • 11.11.1 Invitae Corporation Company Details
    • 11.11.2 Invitae Corporation Business Overview and Its Total Revenue
    • 11.11.3 Invitae Corporation Non-Oncology Precision Medicine Introduction
    • 11.11.4 Invitae Corporation Revenue in Non-Oncology Precision Medicine Business (2016-2021)
    • 11.11.5 Invitae Corporation Recent Development
  • 11.12 Opko Health, Inc.
    • 11.12.1 Opko Health, Inc. Company Details
    • 11.12.2 Opko Health, Inc. Business Overview and Its Total Revenue
    • 11.12.3 Opko Health, Inc. Non-Oncology Precision Medicine Introduction
    • 11.12.4 Opko Health, Inc. Revenue in Non-Oncology Precision Medicine Business (2016-2021)
    • 11.12.5 Opko Health, Inc. Recent Development
  • 11.13 Teva Pharmaceutical Industries Ltd.
    • 11.13.1 Teva Pharmaceutical Industries Ltd. Company Details
    • 11.13.2 Teva Pharmaceutical Industries Ltd. Business Overview and Its Total Revenue
    • 11.13.3 Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Introduction
    • 11.13.4 Teva Pharmaceutical Industries Ltd. Revenue in Non-Oncology Precision Medicine Business (2016-2021)
    • 11.13.5 Teva Pharmaceutical Industries Ltd. Recent Development

12 Analyst's Viewpoints/Conclusion

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source

    Summary:
    Get latest Market Research Reports on Non-Oncology Precision Medicine. Industry analysis & Market Report on Non-Oncology Precision Medicine is a syndicated market report, published as Global Non-Oncology Precision Medicine Key Trends and Opportunities to 2027. It is complete Research Study and Industry Analysis of Non-Oncology Precision Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$6,600.00
    		$9,900.00
    		$13,200.00
    		5,260.20
    		7,890.30
    		10,520.40
    		6,138.00
    		9,207.00
    		12,276.00
    		1,009,008.00
    		1,513,512.00
    		2,018,016.00
    		550,638.00
    		825,957.00
    		1,101,276.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo